Preferred Label : Infigratinib Phosphate;
NCIt synonyms : N'-(2,6-Dichloro-3,5-dimethoxyphenyl)-N-(6-(4-(4-ethylpiperazin-1-yl)anilino)pyrimidin-4-yl)-N-methylurea
Phosphate (1:1);
NCIt definition : The phosphate salt form of infigratinib, an orally bioavailable pan-inhibitor of human
fibroblast growth factor receptors (FGFRs) with potential antiangiogenic and antineoplastic
activities. Upon administration, infigratinib selectively binds to and inhibits the
activities of FGFRs, which may result in the inhibition of angiogenesis and cell proliferation,
and the induction of cell death in tumors with activating FGFR amplifications, mutations,
or fusions. FGFRs are a family of receptor tyrosine kinases that are involved in tumor
cell differentiation and proliferation, tumor angiogenesis, and tumor cell survival.
Activating FGFR amplifications, mutations, or fusions occur in various cancer cell
types.;
UNII : 58BH47BV6S;
InChIKey : GUQNHCGYHLSITB-UHFFFAOYSA-N;
CAS number : 1310746-10-1;
Drug name : Truseltiq;
NCI Metathesaurus CUI : CL1412340;
Origin ID : C175088;
UMLS CUI : C5421156;
Semantic type(s)
concept_is_in_subset
has_free_acid_or_base_form
has_target
is_component_of_chemotherapy_regimen
is_salt_form_of